Hodgkin's lymphoma. II: Treatment and delayed morbidity.

about

Second lethal events associated with treatment for Hodgkin's disease: a review of 2980 patients treated in a single Mexican institute.Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.Treatment of Hodgkin's lymphoma.

P2860

Q34244422-36E08445-F80E-45BD-9E44-38862F4EEDA0 Q42286928-AD1C823F-4875-42D2-9F72-37EC67D76170 Q42762789-C1D630D7-ADC2-4060-BC77-C66E7A966EE8

P2860

Hodgkin's lymphoma. II: Treatment and delayed morbidity.

Item

http://www.wikidata.org/entity/Q35662615

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Hodgkin's lymphoma. II: Treatment and delayed morbidity.

@ast

Hodgkin's lymphoma. II: Treatment and delayed morbidity.

@en

type

Item

label

Hodgkin's lymphoma. II: Treatment and delayed morbidity.

@ast

Hodgkin's lymphoma. II: Treatment and delayed morbidity.

@en

prefLabel

Hodgkin's lymphoma. II: Treatment and delayed morbidity.

@ast

Hodgkin's lymphoma. II: Treatment and delayed morbidity.

@en

P1476

Hodgkin's lymphoma. II: Treatment and delayed morbidity.

@en

P2093

Carde P

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease.

Single agent palliative chemotherapy for end-stage Hodgkin's disease.

Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease.

The results of radiotherapy for Hodgkins' disease

Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.

Protective effect of medroxyprogesterone acetate plus testosterone against radiation-induced damage to the reproductive function of male rats and their offspring.

Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.

P304

173-176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.305.6846.173

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

6846

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P577

1992-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21667128

http://www.w3.org/2001/XMLSchema#string

P698

1489407

http://www.w3.org/2001/XMLSchema#string

P932

1883215

http://www.w3.org/2001/XMLSchema#string

Hodgkin's lymphoma. II: Treatment and delayed morbidity.

about

P2860

P2860

Hodgkin's lymphoma. II: Treatment and delayed morbidity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932